Compounds > nobiletin
Page last updated: 2024-08-25

nobiletin and Metastase

nobiletin has been researched along with Metastase in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liao, YC; Shi, MD; Shih, YW; Tsai, LY1
Chen, CJ; Chen, MK; Chien, SY; Hsieh, MJ; Yang, SF1
Ahn, KS; Baek, SH; Chang, IM; Choi, SH; Kim, SH; Kim, SM; Lee, JH; Nam, D; Shim, BS1

Other Studies

3 other study(ies) available for nobiletin and Metastase

ArticleYear
Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Jun-15, Volume: 20, Issue:8-9

    Topics: Apigenin; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Cell Survival; Chromones; Flavones; Hep G2 Cells; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase 1; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Pseudopodia

2013
Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2.
    Expert opinion on therapeutic targets, 2015, Volume: 19, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cell Movement; Flavones; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Xenograft Model Antitumor Assays

2015
Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
    Pharmaceutical biology, 2012, Volume: 50, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Electrophoretic Mobility Shift Assay; Flavones; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; NF-kappa B; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2012